| Clinical data | |
|---|---|
| Other names | 17α-BP; 17α-Bromopregn-4-ene-3,20-dione |
| Drug class | Progestogen;Progestin |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C21H29BrO2 |
| Molar mass | 393.365 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
17α-Bromoprogesterone (17α-BP) is aprogestin which was first described in 1957 and was never marketed.[1][2][3][4] It is about twice aspotent asprogesterone in terms ofprogestogenic activity in animalbioassays.[1] 17α-BP is aparent compound ofhaloprogesterone (6α-fluoro-17α-bromoprogesterone) and6α-methyl-17α-bromoprogesterone.[5]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byadding missing information. |